chevron_leftBack
As of 24 April 2025, Jamjoom Pharmaceuticals Factory Co. has a market cap of $2.86B USD, ranking #4249 globally and #52 in Saudi Arabia. It ranks #369 in the Healthcare sector, and #66 in the Drug Manufacturers - Specialty & Generic industry.
Key Stats
Market Cap
$2.86BUSD
10.74B SAR
Enterprise Value
$2.79BUSD
10.48B SAR
Revenue (TTM)
$351.5MUSD
1.32B SAR
EBITDA (TTM)
$113.15MUSD
424.44M SAR
Net Income (TTM)
$95.05MUSD
356.52M SAR
EBITDA Margin
32%
Profit Margin
27%
PE Ratio
30.1
Company Profile
Country (HQ)
Sector
Healthcare
CEO
Tarek Youssef Hosni
open_in_new
Founded
1994
Website
jamjoompharma.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| -2.1% | -4.2% | -4.8% | -10% | -8.2% | 16% |
Upcoming Earnings
Earnings Date
Sun, Apr 27
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
4015
شركة مصنع جمجوم للأدوية
ISIN: SA15QGU1UNH6
Shares Out.:
Shares Outstanding:
70.0M1
Shares Float:
21.0M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
150.20 SAR |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Jamjoom Pharmaceuticals Factory Co.
Jamjoom Pharmaceuticals Factory Company manufactures and markets pharmaceutical products in the Kingdom of Saudi Arabia and internationally. The company offers products human medicines, nutraceuticals, antibiotics, general analgesics, medicines for treatment of cough, allergy, asthma, heart diseases, blood pressure, diarrhea, vomiting, ulcer, and acidity, as well as various skin infections, cancer diseases, eye drops and ointments, and cosmeceuticals. Jamjoom Pharmaceuticals Factory Company was founded in 1994 and is based in Jeddah, the Kingdom of Saudi Arabia.
